Tag: Libtayo

Overview of Libtayo, First FDA-Approved Drug for Metastatic Cutaneous Squamous Cell Carcinoma (CSCC) When Surgery or Radiation Isn’t an Option

Overview of Libtayo, First New FDA-Approved Drug for Metastatic Cutaneous Squamous Cell Carcinoma (CSCC)

Susan (Sue) Treiman is an award-winning newspaper reporter, television producer, website executive, and corporate communications ...

READ MORE